Form 4: Celestica Director Sells $2.4M in Common Shares

A director at Celestica Inc. sold 25,000 common shares for approximately $2.47 million, reducing their direct beneficial ownership to 1,784 shares.

Summary

• Michael Max Wilson, a Director of Celestica Inc. (CLS), sold 25,000 common shares.
• The transaction occurred on January 6, 2025.
• The shares were sold at a weighted average price of $98.73 per share, totaling approximately $2,468,250.
• The sale was executed pursuant to a Rule 10b5-1 trading plan.
• Following the transaction, Michael Max Wilson directly beneficially owns 1,784 common shares.
• The reported price was converted from Canadian dollars to U.S. dollars using the Bank of Canada exchange rate on the transaction date.
• The balance of 1,784 shares reflects the inclusion of 9,117 common shares that were inadvertently omitted from the reporting person's Form 3 filed on December 19, 2024.

Sentiment

Score: 4

Explanation: A director selling a significant portion of their holdings, even under a 10b5-1 plan, can be perceived negatively by the market, though the plan mitigates immediate concerns about insider sentiment. The correction of an omission from a previous filing adds a minor administrative negative.

Positives

• The transaction was made pursuant to a Rule 10b5-1 trading plan, indicating a pre-planned sale rather than an immediate reaction to market conditions.

Negatives

• A director sold a significant number of shares (25,000), substantially reducing their direct beneficial ownership.

Risks

• Potential negative market perception due to a director selling a large block of shares, which could be interpreted as a lack of confidence, although mitigated by the 10b5-1 plan.

Future Outlook

The filing does not contain forward-looking statements or guidance regarding the company's future performance or strategic direction.

Management Comments

• The reporting person undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Industry Context

This filing is an insider trading report and does not provide information directly related to broader industry trends or competitors, focusing solely on a director's personal stock transaction.

Comparison to Industry Standards

• NA

Corporate Governance

Stakeholder Impact

• Shareholders: May interpret the director's sale as a signal, potentially leading to negative sentiment, though the 10b5-1 plan suggests a pre-determined sale.

Next Steps

• The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request.

Key Dates

Recommendation

While a director's sale of a substantial number of shares might typically raise concerns, the transaction was executed under a Rule 10b5-1 plan, indicating a pre-scheduled sale rather than a reaction to new negative information. This mitigates the immediate negative signal. The correction of a prior omission is an administrative detail. Without further company-specific news or financial updates, the filing alone does not warrant a 'sell' recommendation, but the insider selling activity suggests a 'hold' rather than a 'buy' for now, pending broader company performance analysis.

Keywords

Celestica Inc., CLS, Form 4, Insider Trading, Director Sale, Equity Transaction, Michael Max Wilson, 10b5-1 Plan